TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Spyglass Ophthalmics Stock

Spyglass Ophthalmics Stock

www.spyglasspharma.comHealthcare / Medical DevicesFounded: 2019

Spyglass Pharma is a drug delivery and ophthalmic platform for patients with eye problems. With a mission to treat glaucoma and cataract surgery patients, Spyglass Pharma is using drug innovation technology to improve the standard of eye care through consistent drug design and delivery. Spyglass Pharma was founded by Glenn Sussman in 2019 and is headquartered in Los Angeles, CA.

Buy or sell Spyglass Ophthalmics stockLearn more about Spyglass Ophthalmics IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Spyglass Ophthalmics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Spyglass Ophthalmics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Spyglass Ophthalmics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Spyglass Ophthalmics investors also invested in these private companies

New Enterprise Associates
Ra Capital Management
Samsara Biocapital
Vertex Ventures HC
Vensana Capital

Team

Management Team

Malik Kahook MD
Co-Founder, President & Executive Chairman
James Dennewill
Chief Operating Officer
Glenn Sussman
Co-Founder & Chief Technology Officer
Patrick Mooney
Chief Executive Officer, Vice President of Research and Development & TalentWell Marketing Specialist

Board Members

Ali Behbahani MD
New Enterprise Associates

Frequently Asked Questions About Spyglass Ophthalmics’ Stock

plusminus
Can you buy Spyglass Ophthalmics’ stock?
Spyglass Ophthalmics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Spyglass Ophthalmics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Spyglass Ophthalmics’ stock?
Yes, you can sell stock of a private company like Spyglass Ophthalmics. Forge can help you sell your Spyglass Ophthalmics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Spyglass Ophthalmics’ stock price?
Spyglass Ophthalmics is a privately held company and therefore does not have a public stock price. However, you may access Spyglass Ophthalmics’ private market stock price with Forge Data.
plusminus
What is Spyglass Ophthalmics’ stock ticker symbol?
Spyglass Ophthalmics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Spyglass Ophthalmics in the Medical Devices sector

Neuralink

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$3.45B

Synchron

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$400.53MM

HistoSonics

Sector
Healthcare / Medical Devices
 
 

Beta Bionics

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$263MM

Levels

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$310.36MM

CMR Surgical

Sector
Healthcare / Medical Devices
 
 

Imperative Care

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$1.35B

Eko Health

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$268.75MM

Verily Life Sciences

Sector
Healthcare / Medical Devices
 
 

News Highlights

CITYBIZ 07/11/2023
SpyGlass Pharma Closes $90M Series C
SpyGlass Pharma, an Aliso Viejo, CA-based ophthalmic therapeutics company, raised $90M in Series C funding. The round was led by RA Capital Management alongside existing investors New Enterprise Associates and Vensana Capital, as well as new investors Samsara BioCapital and Vertex Ventures HC.

Trending Companies

Frequently Asked Questions

Updated on: Apr 29, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.